WNT10B functional dualism: β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer

Hirohide Yoshikawa, Kenichi Matsubara, Xiaoling Zhou, Shu Okamura, Takahiko Kubo, Yaeko Murase, Yuko Shikauchi, Manel Esteller, James G. Hennan, Wei Wang Xin, Curtis C. Harris

Research output: Contribution to journalArticle

Abstract

We found aberrant DNA methylation of the WNT10B promoter region in 46% of primary hepatocellular carcinoma (HCC) and 15% of colon cancer samples. Three of 10 HCC and one of two colon cancer cell lines demonstrated low or no expression, and 5-aza-2′deoxycytidine reactivated WNT10B expression with the induction of demethylation, indicating that WNT10B is silenced by DNA methylation in some cancers, whereas WNT10B expression is up-regulated in seven of the 10 HCC cell lines and a colon cancer cell line. These results indicate that WNT10B can be deregulated by either overexpression or silencing in cancer. We found that WNT10B up-regulated β-catenin/Tcf activity. However, WNT10B-overexpressing cells demonstrated a reduced growth rate and anchorage-independent growth that is independent of the β-catenin/Tcf activation, because mutant β-catenin-transduced cells did not suppress growth, and dominant-negative hTcf-4 failed to alleviate the growth suppression by WNT10B. Although WNT10B expression alone inhibits cell growth, it acts synergistically with the fibroblast growth factor (FGF) to stimulate cell growth. WNT10B is bifunctional, one function of which is involved in β-catenin/Tcf activation, and the other function is related to the down-regulation of cell growth through a different mechanism. We suggest that FGF switches WNT10B from a negative to a positive cell growth regulator.

Original languageEnglish (US)
Pages (from-to)4292-4303
Number of pages12
JournalMolecular Biology of the Cell
Volume18
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Catenins
Growth
Neoplasms
Colonic Neoplasms
Hepatocellular Carcinoma
Fibroblast Growth Factors
DNA Methylation
Cell Line
Genetic Promoter Regions
Down-Regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

WNT10B functional dualism : β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. / Yoshikawa, Hirohide; Matsubara, Kenichi; Zhou, Xiaoling; Okamura, Shu; Kubo, Takahiko; Murase, Yaeko; Shikauchi, Yuko; Esteller, Manel; Hennan, James G.; Xin, Wei Wang; Harris, Curtis C.

In: Molecular Biology of the Cell, Vol. 18, No. 11, 11.2007, p. 4292-4303.

Research output: Contribution to journalArticle

Yoshikawa, H, Matsubara, K, Zhou, X, Okamura, S, Kubo, T, Murase, Y, Shikauchi, Y, Esteller, M, Hennan, JG, Xin, WW & Harris, CC 2007, 'WNT10B functional dualism: β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer', Molecular Biology of the Cell, vol. 18, no. 11, pp. 4292-4303. https://doi.org/10.1091/mbc.E06-10-0889
Yoshikawa, Hirohide ; Matsubara, Kenichi ; Zhou, Xiaoling ; Okamura, Shu ; Kubo, Takahiko ; Murase, Yaeko ; Shikauchi, Yuko ; Esteller, Manel ; Hennan, James G. ; Xin, Wei Wang ; Harris, Curtis C. / WNT10B functional dualism : β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. In: Molecular Biology of the Cell. 2007 ; Vol. 18, No. 11. pp. 4292-4303.
@article{0da3c14a790c482c8da3ce26b9a84bf1,
title = "WNT10B functional dualism: β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer",
abstract = "We found aberrant DNA methylation of the WNT10B promoter region in 46{\%} of primary hepatocellular carcinoma (HCC) and 15{\%} of colon cancer samples. Three of 10 HCC and one of two colon cancer cell lines demonstrated low or no expression, and 5-aza-2′deoxycytidine reactivated WNT10B expression with the induction of demethylation, indicating that WNT10B is silenced by DNA methylation in some cancers, whereas WNT10B expression is up-regulated in seven of the 10 HCC cell lines and a colon cancer cell line. These results indicate that WNT10B can be deregulated by either overexpression or silencing in cancer. We found that WNT10B up-regulated β-catenin/Tcf activity. However, WNT10B-overexpressing cells demonstrated a reduced growth rate and anchorage-independent growth that is independent of the β-catenin/Tcf activation, because mutant β-catenin-transduced cells did not suppress growth, and dominant-negative hTcf-4 failed to alleviate the growth suppression by WNT10B. Although WNT10B expression alone inhibits cell growth, it acts synergistically with the fibroblast growth factor (FGF) to stimulate cell growth. WNT10B is bifunctional, one function of which is involved in β-catenin/Tcf activation, and the other function is related to the down-regulation of cell growth through a different mechanism. We suggest that FGF switches WNT10B from a negative to a positive cell growth regulator.",
author = "Hirohide Yoshikawa and Kenichi Matsubara and Xiaoling Zhou and Shu Okamura and Takahiko Kubo and Yaeko Murase and Yuko Shikauchi and Manel Esteller and Hennan, {James G.} and Xin, {Wei Wang} and Harris, {Curtis C.}",
year = "2007",
month = "11",
doi = "10.1091/mbc.E06-10-0889",
language = "English (US)",
volume = "18",
pages = "4292--4303",
journal = "Molecular Biology of the Cell",
issn = "1059-1524",
publisher = "American Society for Cell Biology",
number = "11",

}

TY - JOUR

T1 - WNT10B functional dualism

T2 - β-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer

AU - Yoshikawa, Hirohide

AU - Matsubara, Kenichi

AU - Zhou, Xiaoling

AU - Okamura, Shu

AU - Kubo, Takahiko

AU - Murase, Yaeko

AU - Shikauchi, Yuko

AU - Esteller, Manel

AU - Hennan, James G.

AU - Xin, Wei Wang

AU - Harris, Curtis C.

PY - 2007/11

Y1 - 2007/11

N2 - We found aberrant DNA methylation of the WNT10B promoter region in 46% of primary hepatocellular carcinoma (HCC) and 15% of colon cancer samples. Three of 10 HCC and one of two colon cancer cell lines demonstrated low or no expression, and 5-aza-2′deoxycytidine reactivated WNT10B expression with the induction of demethylation, indicating that WNT10B is silenced by DNA methylation in some cancers, whereas WNT10B expression is up-regulated in seven of the 10 HCC cell lines and a colon cancer cell line. These results indicate that WNT10B can be deregulated by either overexpression or silencing in cancer. We found that WNT10B up-regulated β-catenin/Tcf activity. However, WNT10B-overexpressing cells demonstrated a reduced growth rate and anchorage-independent growth that is independent of the β-catenin/Tcf activation, because mutant β-catenin-transduced cells did not suppress growth, and dominant-negative hTcf-4 failed to alleviate the growth suppression by WNT10B. Although WNT10B expression alone inhibits cell growth, it acts synergistically with the fibroblast growth factor (FGF) to stimulate cell growth. WNT10B is bifunctional, one function of which is involved in β-catenin/Tcf activation, and the other function is related to the down-regulation of cell growth through a different mechanism. We suggest that FGF switches WNT10B from a negative to a positive cell growth regulator.

AB - We found aberrant DNA methylation of the WNT10B promoter region in 46% of primary hepatocellular carcinoma (HCC) and 15% of colon cancer samples. Three of 10 HCC and one of two colon cancer cell lines demonstrated low or no expression, and 5-aza-2′deoxycytidine reactivated WNT10B expression with the induction of demethylation, indicating that WNT10B is silenced by DNA methylation in some cancers, whereas WNT10B expression is up-regulated in seven of the 10 HCC cell lines and a colon cancer cell line. These results indicate that WNT10B can be deregulated by either overexpression or silencing in cancer. We found that WNT10B up-regulated β-catenin/Tcf activity. However, WNT10B-overexpressing cells demonstrated a reduced growth rate and anchorage-independent growth that is independent of the β-catenin/Tcf activation, because mutant β-catenin-transduced cells did not suppress growth, and dominant-negative hTcf-4 failed to alleviate the growth suppression by WNT10B. Although WNT10B expression alone inhibits cell growth, it acts synergistically with the fibroblast growth factor (FGF) to stimulate cell growth. WNT10B is bifunctional, one function of which is involved in β-catenin/Tcf activation, and the other function is related to the down-regulation of cell growth through a different mechanism. We suggest that FGF switches WNT10B from a negative to a positive cell growth regulator.

UR - http://www.scopus.com/inward/record.url?scp=35848970078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848970078&partnerID=8YFLogxK

U2 - 10.1091/mbc.E06-10-0889

DO - 10.1091/mbc.E06-10-0889

M3 - Article

C2 - 17761539

AN - SCOPUS:35848970078

VL - 18

SP - 4292

EP - 4303

JO - Molecular Biology of the Cell

JF - Molecular Biology of the Cell

SN - 1059-1524

IS - 11

ER -